Frailty and Mortality Risk in COPD: A Cohort Study Comparing the Fried Frailty Phenotype and Short Physical Performance Battery
Lisa Jane Brighton,Claire M Nolan,Ruth E Barker,Suhani Patel,Jessica A Walsh,Oliver Polgar,Samantha SC Kon,Wei Gao,Catherine J Evans,Matthew Maddocks,William DC Man
DOI: https://doi.org/10.2147/COPD.S375142
2023-01-20
International Journal of COPD
Abstract:Lisa Jane Brighton, 1 Claire M Nolan, 2, 3 Ruth E Barker, 2, 4, 5 Suhani Patel, 2, 4 Jessica A Walsh, 2 Oliver Polgar, 2 Samantha SC Kon, 2, 4, 6 Wei Gao, 1 Catherine J Evans, 1, 7 Matthew Maddocks, 1 William DC Man 2, 4, 8, 9 1 Cicely Saunders Institute of Palliative Care, Policy and Rehabilitation, King's College London, London, UK; 2 Harefield Respiratory Research Group, Royal Brompton and Harefield Hospitals, Guy's and St Thomas NHS Foundation Trust, London, UK; 3 Division of Physiotherapy, College of Health, Medicine and Life Sciences, Brunel University London, London, UK; 4 National Heart and Lung Institute, Imperial College, London, UK; 5 Insight Innovation, Wessex Academic Health Science Network, Southampton, UK; 6 Department of Respiratory Medicine, The Hillingdon Hospital NHS Trust, London, UK; 7 Brighton General Hospital, Sussex Community NHS Foundation Trust, Brighton, UK; 8 Harefield Pulmonary Rehabilitation Unit, Guy's and St Thomas NHS Foundation Trust, London, UK; 9 Faculty of Life Sciences & Medicine, King's College London, London, UK Correspondence: Lisa Jane Brighton, Cicely Saunders Institute, Bessemer Road, Denmark Hill, London, SE5 9PJ, UK, Tel +44 020 7848 5041, Email Background: Identifying frailty in people with chronic obstructive pulmonary disease (COPD) is deemed important, yet comparative characteristics of the most commonly used frailty measures in COPD are unknown. This study aimed to compare how the Fried Frailty Phenotype (FFP) and Short Physical Performance Battery (SPPB) characterise frailty in people with stable COPD, including prevalence of and overlap in identification of frailty, disease and health characteristics of those identified as living with frailty, and predictive value in relation to survival time. Methods: Cohort study of people with stable COPD attending outpatient clinics. Agreement between frailty classifications was described using Cohen's Kappa. Disease and health characteristics of frail versus not frail participants were compared using t-, Mann–Whitney U and Chi-Square tests. Predictive value for mortality was examined with multivariable Cox regression. Results: Of 714 participants, 421 (59%) were male, mean age 69.9 years (SD 9.7), mean survival time 2270 days (95% CI 2185– 2355). Similar proportions were identified as frail using the FFP (26.2%) and SPPB (23.7%) measures; classifications as frail or not frail matched in 572 (80.1%) cases, showing moderate agreement (Kappa = 0.469, SE = 0.038, p < 0.001). Discrepancies seemed driven by FFP exhaustion and weight loss criteria and the SPPB balance component. People with frailty by either measure had worse exercise capacity, health-related quality of life, breathlessness, depression and dependence in activities of daily living. In multivariable analysis controlling for the Age Dyspnoea Obstruction index, sex, BMI, comorbidities and exercise capacity, both the FFP and SPPB had predictive value in relation to mortality (FFP aHR = 1.31 [95% CI 1.03– 1.66]; SPPB aHR = 1.29 [95% CI 0.99– 1.68]). Conclusion: In stable COPD, both the FFP and SPPB identify similar proportions of people living with/without frailty, the majority with matching classifications. Both measures can identify individuals with multidimensional health challenges and increased mortality risk and provide additional information alongside established prognostic variables. Keywords: respiratory disease, chronic obstructive pulmonary disease, frailty, survival Approximately one in five people with COPD are also living with frailty. 1 Frailty is a multidimensional syndrome, characterised by decreased reserve and diminished resistance to stressors. 2 It is relevant across diagnoses, including multimorbidity, and can provide a holistic measure of a person's health and risk of adverse outcomes. People with both COPD and frailty experience poorer physical and mental health, 3 higher risk of readmission 4 and mortality, 5 and are at higher risk of not receiving disease modifying treatments 3,6 compared to those with COPD without frailty. Identifying frailty in respiratory research and practice has been recognised as important by public and professional stakeholders. 7 Several measures have been used to identify frailty in people with COPD, and there is no universal agreement on which frailty measure should be used. 8 While comprehensive geriatric assessment is the gold-standard approac -Abstract Truncated-
English Else